𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Intermittent Fugu parathyroid hormone 1 (1–34) is an anabolic bone agent in young male rats and osteopenic ovariectomized rats

✍ Scribed by Julie F. McManus; Rachel A. Davey; Helen E. MacLean; Elizabeth A. Doust; W.S. Maria Chiu; Natalie A. Sims; Mary L. Bouxsein; Vaida Glatt; Jeffrey D. Zajac; Janine A. Danks

Book ID
116320602
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
1004 KB
Volume
42
Category
Article
ISSN
8756-3282

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Maintaining bone mass by bisphosphonate
Maintaining bone mass by bisphosphonate incadronate disodium (YM175) sequential treatment after discontinuation of intermittent human parathyroid hormone (1-34) administration in ovariectomized rats
✍ Yuichi Takano; Tatsuhiko Tanizawa; Tasuku Mashiba; Naoto Endo; Saburo Nishida; H 📂 Article 📅 2009 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 791 KB

Intermittent treatment with human parathyroid hormone (1-34) ] stimulates bone formation and increases cancellous bone mass in ovariectomized (OW) rats. But PTH-induced cancellous bone rapidly disappears upon cessation of treatment. The fate of cortical bone treated by PTH has not been well characte

Effects of combined and separate intermi
Effects of combined and separate intermittent administration of low-dose human parathyroid hormone fragment (1–34) and 17β-estradiol on bone histomorphometry in ovariectomized rats with established osteopenia
✍ V. Shen; D. W. Dempster; R. W. E. Mellish; R. Birchman; W. Horbert; R. Lindsay 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 819 KB

To evaluate the potential use of a combination of parathyroid hormone (PTH) and estrogen as therapy for osteoporosis, we examined the effects of combined and separate administration of low-dose PTH and estradiol in ovariectomized rats with established osteopenia. Ovariectomized rats were untreated f